CG Oncology, Inc. (CGON)
56.95
+2.03
(+3.70%)
USD |
NASDAQ |
Jun 11, 15:06
CG Oncology Market Cap : 5.012B for June 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 4.833B |
| June 09, 2026 | 4.987B |
| June 08, 2026 | 4.788B |
| June 05, 2026 | 4.728B |
| June 04, 2026 | 4.936B |
| June 03, 2026 | 4.789B |
| June 02, 2026 | 4.887B |
| June 01, 2026 | 5.213B |
| May 29, 2026 | 5.482B |
| May 28, 2026 | 5.345B |
| May 27, 2026 | 5.024B |
| May 26, 2026 | 5.114B |
| May 22, 2026 | 5.309B |
| May 21, 2026 | 5.337B |
| May 20, 2026 | 5.351B |
| May 19, 2026 | 5.230B |
| May 18, 2026 | 5.200B |
| May 15, 2026 | 5.530B |
| May 14, 2026 | 5.745B |
| May 13, 2026 | 6.114B |
| May 12, 2026 | 5.955B |
| May 11, 2026 | 5.728B |
| May 08, 2026 | 5.752B |
| May 07, 2026 | 5.716B |
| May 06, 2026 | 5.619B |
| Date | Value |
|---|---|
| May 05, 2026 | 5.550B |
| May 04, 2026 | 5.594B |
| May 01, 2026 | 5.476B |
| April 30, 2026 | 5.514B |
| April 29, 2026 | 5.350B |
| April 28, 2026 | 5.416B |
| April 27, 2026 | 5.521B |
| April 24, 2026 | 5.675B |
| April 23, 2026 | 5.775B |
| April 22, 2026 | 5.774B |
| April 21, 2026 | 5.936B |
| April 20, 2026 | 5.817B |
| April 17, 2026 | 6.067B |
| April 16, 2026 | 5.481B |
| April 15, 2026 | 5.592B |
| April 14, 2026 | 5.559B |
| April 13, 2026 | 5.594B |
| April 10, 2026 | 5.594B |
| April 09, 2026 | 5.665B |
| April 08, 2026 | 5.690B |
| April 07, 2026 | 5.768B |
| April 06, 2026 | 5.581B |
| April 02, 2026 | 5.575B |
| April 01, 2026 | 5.518B |
| March 31, 2026 | 5.592B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cogent Biosciences, Inc. | 5.517B |
| Vera Therapeutics, Inc. | 2.399B |
| Arrowhead Pharmaceuticals, Inc. | 10.52B |
| Oncolytics Biotech, Inc. | 93.41M |
| Sangamo Therapeutics, Inc. | 61.73M |
Market Cap Related Metrics
| PS Ratio | 891.63 |
| PEG Ratio | -0.3989 |
| Price to Book Value | 4.591 |
| Price | 56.95 |
| Earnings Yield | -4.11% |
| PEGY Ratio | -0.3989 |